Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
LLY compared with LNAI: revenue, margins and what each company keeps, and the suppliers and customers both name
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
LNAI
Lunai Bioworks Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
LLY
ELI Lilly & Co
vs
LNAI
Lunai Bioworks Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
LLY, solid
LNAI, dashed
Supply-chain overlap
Revenue flow
LNAI: latest quarter is a loss; flow not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only LLY
29
MCK
McKesson
customer
CAH
Cardinal Health
customer
VEEV
Veeva Systems
supplier
UTHR
United Therapeutics
customer
25 more · LLY chain
›
Shared
0
No disclosed counterparties: LNAI.
Only LNAI
0
None
Role chip = supplier or customer
Source: SEC EDGAR
LLY
ELI Lilly & Co
Change
1,430.76
▲
+1.52%
Mkt cap
$1.3T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
LNAI
Lunai Bioworks Inc.
Change
0.11
▼
−53.83%
Regular session
Nov 4 '26
Mkt cap
$829,678
Revenue
$31,050
Q4 FY26
Revenue
—
vs
Compare
Regular session
Nov 4 '26
LLY
ELI Lilly & Co
vs
LNAI
Lunai Bioworks Inc.
1,430.76
▲
+1.52%
Price
0.11
▼
−53.83%
$1.3T
Mkt cap
$829,678
Q3 FY26
$24.4B
Revenue
$31,050
Q4 FY26
FY25
$65.2B
Revenue
—
Change
Change
LLY
1,430.76
▲
+1.52%
vs
LNAI
0.11
▼
−53.83%
Regular session
Nov 4 '26